33 unknown. 33 Phase 3, 6 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 33 | Unknown 33 |
| Phase 2 | 6 | Unknown 6 |
Follow Blood Coagulation Disorders: new trials by email Literature Review of Blood Coagulation Disorders trials Research Report on Blood Coagulation Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparison of Outcomes Between Low Dose Emicizumab and Factor VIII in Clinically Severe Hemophilia A "Emicizumab", "HEMLIBRA®" - Severe Hemophilia A Without Inhibitor, Joint Bleed | Phase 2 / Phase 3 | Unknown | Chulalongkorn University | 15 | 2023-06-22 | 2024-03-05 |
| Extension Study of Herombopag for Pediatric Patients With Chronic Immune Thrombocytopenia Herombopag - Immune Thrombocytopenia | Phase 3 | Unknown | Jiangsu HengRui Medicine Co., Ltd. | 117 | 2023-01-23 | 2023-01-17 |
| Fibrin Sealant in Eyelid Surgery Tisseel - Blepharoptosis, Ecchymosis; Eyelid | Phase 2 / Phase 3 | Unknown | University of Calgary | 30 | 2022-05-01 | 2022-05-03 |
| Clinical Study of Recombinant Human Activated Coagulation Factor VII for Injection in Patients With Hemophilia With Inhibitor Recombinant human activated coagulation factor VII for injection - Hemophilia A, Hemophilia B | Phase 3 | Unknown | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 50 | 2022-04-28 | 2022-08-04 |
| IgIV Plus Prednisone vs High-dose Dexamethasone for ITP Neofordex®, Intravenous immunoglobulins - Immune Thrombocytopenia (ITP) | Phase 3 | Unknown | Assistance Publique - Hôpitaux de Paris | 272 | 2022-04-07 | 2023-09-11 |
| Herombopag + rhTPO in Severe Immune Thrombocytopenia rhTPO, Herombopag - Immune Thrombocytopenia | Phase 3 | Unknown | Yin Jie | 90 | 2022-01-01 | 2022-04-26 |
| Atorvastatin in Management of Newly Diagnosed ITP Atorvastatin 20mg, Atorvastatin 10mg, Dexamethasone - Immune Thrombocytopenia, Purpura, Thrombocytopenic | Phase 2 / Phase 3 | Unknown | Shandong University | 30 | 2021-11-01 | 2021-09-05 |
| TPO-RAs Combined With Anti-CD20 Antibody in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies Combined use of TPO-RAs with low-dose anti-CD20 antibody, The best available therapy - Immune Thrombocytopenia (ITP), Autoantibodies | Phase 2 / Phase 3 | Unknown | Institute of Hematology & Blood Diseases Hospital, China | 94 | 2021-06-06 | 2024-07-03 |
| Safety,Efficacy and Pharmacokinetics Evaluation of SCT800 in Previously Treated Paediatric Patients With Severe Haemophilia A. Recombinant Human Coagulation FVIII - Hemophilia A | Phase 3 | Unknown | Sinocelltech Ltd. | 70 | 2019-12-20 | 2019-05-13 |
| Efficacy of Colchicine to Prevent Skin Relapses in Adult's IgA Vasculitis Colchicine - IgA Vasculitis | Phase 3 | Unknown | Assistance Publique - Hôpitaux de Paris | 264 | 2019-11-12 | 2021-10-04 |
| Safety, Efficacy Evaluation of Recombinant Coagulation Factor VIII Injection in Subjects With Hemophilia A. Recombinant Human Coagulation FVIII - Hemophilia A | Phase 3 | Unknown | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 64 | 2019-05-15 | 2019-08-19 |
| Decitabine Combining Dexamethasone Versus Dexamethasone in Management of ITP Decitabine, Dexamethasone - Purpura, Thrombocytopenic, Idiopathic, Immune Thrombocytopenia | Phase 3 | Unknown | Shandong University | 200 | 2018-09-01 | 2018-08-15 |
| Magnesium Sulfate in Thrombotic Thrombocytopenic Purpura in Intensive Care Sulfate, Magnesium, Placebo - Concentrate - Thrombotic Thrombocytopenic Purpura | Phase 3 | Unknown | Assistance Publique - Hôpitaux de Paris | 74 | 2018-05-27 | 2021-10-29 |
| Recombinant Human Thrombopoietin(rhTPO) in Pregnancy With Immune Thrombocytopenia recombinant human thrombopoietin, Platelet Concentrate - Immune Thrombocytopenia | Phase 3 | Unknown | Shandong University | 90 | 2018-05-01 | 2018-04-10 |
| Efficacy and Safety of Unfractionated Heparin on Severe Sepsis With Suspected Disseminated Intravascular Coagulation Heparin Sodium, Saline - Sepsis, Disseminated Intravascular Coagulation | Phase 3 | Unknown | China Medical University, China | 600 | 2018-04-12 | 2023-11-18 |
| Rituximab Combining Bortezomib Versus Rituximab in Management of ITP Rituximab, Bortezomib - Immune Thrombocytopenia, Purpura, Thrombocytopenic, Idiopathic | Phase 3 | Unknown | Shandong University | 200 | 2018-03-01 | 2018-02-23 |
| H. Pylori Eradication for Moderate ITP treatment : H. pylori eradication - Immune Thrombocytopenic Purpura, Helicobacter Pylori | Phase 3 | Unknown | Seoul National University Hospital | 54 | 2017-05-23 | 2018-09-07 |
| Proof-of-Concept: A Pilot, Randomized, Double-Blind Study of Oseltamivir Versus Placebo for Immune Thrombocytopenia Oseltamivir, Placebo - Immune Thrombocytopenia | Phase 3 | Unknown | Unity Health Toronto | 30 | 2016-11-01 | 2020-10-22 |
| Efficacy and Safety Study of SCT800 for On-demand Treatment With in Patients With Hemophilia A SCT800 - Hemophilia A | Phase 3 | Unknown | Sinocelltech Ltd. | 50 | 2016-10-01 | 2016-10-03 |
| Evaluate Efficacy and Safety of Recombinant Factor VIII （rFVIII）Treatment of Severe or Moderately Severe Hemophilia A Recombinant Factor VIII (50 IU/kg), Recombinant Factor VIII (On-demand treatment) - Hemophilia A | Phase 3 | Unknown | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 60 | 2016-08-01 | 2016-10-12 |
Showing 20 of 33. Sign in to see all of them.
Purpura, Thrombocytopenic, Idiopathic (17) · Hemophilia A (8) · Thrombocytopenia (4) · Lymphoma, Follicular (2) · Thrombocythemia, Essential (2) · Anxiety Disorders (1) · Blast Crisis (1) · Blepharoptosis (1) · Blood Loss, Surgical (1) · Burkitt Lymphoma (1) · Congenital Abnormalities (1) · Connective Tissue Diseases (1) · Coronary Artery Disease (1) · Depression (1)
Hematologic Diseases (33) · Hemic and Lymphatic Diseases (33) · Hemorrhagic Disorders (29) · Pathologic Processes (24) · Pathological Conditions, Signs and Symptoms (24) · Hemorrhage (21) · Signs and Symptoms (21) · Blood Platelet Disorders (20) · Skin Manifestations (20) · Immune System Diseases (19) · Cytopenia (18) · Purpura (18) · Thrombotic Microangiopathies (18) · Autoimmune Diseases (17)
Dexamethasone (5) · Immunoglobulins, Intravenous (3) · Inosine Triphosphate (2) · Thrombopoietin (2) · Atorvastatin (1) · Bortezomib (1) · Colchicine (1) · Dapsone (1) · Decitabine (1) · Drug Therapy (1) · Factor VIII (1) · Fibrin Tissue Adhesive (1) · Heparin (1) · Hydrocortisone (1) · Injections (1)
Shandong University (6) · Assistance Publique - Hôpitaux de Paris (5) · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (3) · Green Cross Corporation (2) · Sinocelltech Ltd. (2) · Ain Shams University (1) · Austin Health (1) · China Medical University, China (1) · Chulalongkorn University (1) · Institute of Hematology & Blood Diseases Hospital, China (1) · Jiangsu HengRui Medicine Co., Ltd. (1) · National Institute of Blood and Marrow Transplant (NIBMT), Pakistan (1) · Ottawa Hospital Research Institute (1) · Peking Union Medical College (1) · Peking University People's Hospital (1)
China (14) · France (5) · Canada (3) · United Kingdom (2) · United States (2) · Australia (1) · Egypt (1) · New Zealand (1) · Pakistan (1) · Poland (1) · Russia (1) · South Korea (1) · Thailand (1) · Ukraine (1)
Ming Hou, Dr (3) · Alan Tinmouth, MD MSc (1) · Andleeb Hanif, M.Phil (1) · Barry J.A. Laird, MD (1) · Jie Yin (1) · Karim Punja, MD (1) · Lei Zhang, MD (1) · Marie T. Fallon (1) · Ming Hou (1) · Ming Hou, MD PhD (1) · Ming Hou,, Dr (1) · Mohsen S Elalfy, professor (1)
PMID 19005182, PMID 25247485, PMID 25566808, PMID 26480931, PMID 35643952, PMID 38167115, PMID 39737816, PMID 39874521
2018 (1)